Patents by Inventor Jennifer Hutsell

Jennifer Hutsell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9505814
    Abstract: The present invention provides compositions and pharmaceutical formulations of IaIp derived from plasma. Also provided are methods for the manufacture of the IaIp compositions and formulations, as well as method for the treatment of diseases associated with IaIp dysfunction.
    Type: Grant
    Filed: August 19, 2014
    Date of Patent: November 29, 2016
    Assignees: Baxalta Incorporated, Baxalta GmbH
    Inventors: Shawn F. Bairstow, Jennifer Hutsell, Sindhu Ramachandran
  • Publication number: 20150045538
    Abstract: The present invention provides compositions and pharmaceutical formulations of IaIp derived from plasma. Also provided are methods for the manufacture of the IaIp compositions and formulations, as well as method for the treatment of diseases associated with IaIp dysfunction.
    Type: Application
    Filed: August 19, 2014
    Publication date: February 12, 2015
    Inventors: Shawn F. Bairstow, Jennifer Hutsell, Sindhu Ramachandran
  • Patent number: 8841248
    Abstract: The present invention provides compositions and pharmaceutical formulations of IaIp derived from plasma. Also provided are methods for the manufacture of the IaIp compositions and formulations, as well as method for the treatment of diseases associated with IaIp dysfunction.
    Type: Grant
    Filed: July 22, 2011
    Date of Patent: September 23, 2014
    Assignees: Baxter International Inc., Baxter Healthcare SA
    Inventors: Shawn F. Bairstow, Jennifer Hutsell, Sindhu Ramachandran
  • Publication number: 20120053113
    Abstract: The present invention provides compositions and pharmaceutical formulations of IaIp derived from plasma. Also provided are methods for the manufacture of the IaIp compositions and formulations, as well as method for the treatment of diseases associated with IaIp dysfunction.
    Type: Application
    Filed: July 22, 2011
    Publication date: March 1, 2012
    Applicants: Baxter Healthcare S.A., Baxter International Inc.
    Inventors: Shawn F. Bairstow, Jennifer Hutsell, Sindhu Ramachandran